Nevirapine
- Generic Name
- Nevirapine
- Brand Names
- Viramune
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14N4O
- CAS Number
- 129618-40-2
- Unique Ingredient Identifier
- 99DK7FVK1H
Overview
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
Background
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
Indication
For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
Associated Conditions
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Clinical Trials
FDA Approved Products
Nevirapine
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:200 mg in 1 1
Approved: 2012/08/20
NDC:65162-209
Nevirapine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2022/10/31
NDC:0378-4890
Nevirapine
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:200 mg in 1 1
Approved: 2022/07/07
NDC:65862-027
Nevirapine
Manufacturer:Mylan Pharmaceuticals Inc.
Route:ORAL
Strength:200 mg in 1 1
Approved: 2024/01/15
NDC:0378-4050
Nevirapine
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:200 mg in 1 1
Approved: 2013/09/26
NDC:53808-0680
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath